The Inaugural Birt-Hogg-Dubé (BHD) Symposium, Roskilde, Denmark, September 3rd, 2008 and 8th International Symposium on von Hippel-Lindau Disease, Roskilde, Denmark, September 4th-6th, 2008
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.